Recombinant DNA Technology Market To Surpass US$ 266.8 Bn With A CAGR Of 7.9% By 2030 | Merck & Co., Inc., Pfizer, Inc
Recombinant DNA Technology Growth Recombinant DNA technology allows the mass production of therapeutic proteins, which are characterized b